1. Home
  2. CRTO vs NEO Comparison

CRTO vs NEO Comparison

Compare CRTO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Criteo S.A.

CRTO

Criteo S.A.

HOLD

Current Price

$19.74

Market Cap

929.9M

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.12

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRTO
NEO
Founded
2005
2001
Country
France
United States
Employees
N/A
N/A
Industry
Advertising
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
929.9M
1.0B
IPO Year
2013
2008

Fundamental Metrics

Financial Performance
Metric
CRTO
NEO
Price
$19.74
$8.12
Analyst Decision
Strong Buy
Buy
Analyst Count
11
7
Target Price
$35.27
$11.14
AVG Volume (30 Days)
248.8K
1.5M
Earning Date
05-01-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
38.95
N/A
EPS
2.64
N/A
Revenue
$2,296,692,000.00
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
$5.54
$9.73
P/E Ratio
$7.38
N/A
Revenue Growth
27.65
N/A
52 Week Low
$16.15
$4.72
52 Week High
$35.10
$13.74

Technical Indicators

Market Signals
Indicator
CRTO
NEO
Relative Strength Index (RSI) 65.57 48.48
Support Level $19.23 $7.33
Resistance Level $19.79 $8.89
Average True Range (ATR) 0.73 0.46
MACD 0.19 0.15
Stochastic Oscillator 91.99 67.41

Price Performance

Historical Comparison
CRTO
NEO

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: